To date, several inflammatory mediators have been proposed as AD markers, such as TNF-α, IL-1β, ionized calcium-binding adapter molecule-1 (Iba-1), glial fibrillary acidic protein (GFAP), and nuclear factor kappa B (NF-κB) (Novoa et al., 2022). This evidence concerns the gene GFAP and Alzheimer disease.